Title | Announcement Number | Activity Code | Clinical Trials Status | Expiration Date | Program Official Sort descending |
---|---|---|---|---|---|
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes | PAR-22-131 (R01 Clinical Trial Optional) | R01 | Clinical Trial Optional | 09/08/2025 | Richard Mazurchuk, Ph.D. |